From ‘Accelerate’ To ‘Confirm’: US FDA Launches Transparency Program On Cancer Drug Approvals

 
• By Sue Sutter
Confirm
FDA's oncology center is emphasizing the "confirm" part of the accelerated approval pathway in a new transparency project. • Source: Alamy

More from Review Pathways

More from Pathways & Standards